H.R.7121: Protecting our Pharmaceutical Supply Chain from China Act of 2022

About This Bill

  • This bill was introduced in the 117th Congress
  • This bill is primarily about health
  • Introduced March 17, 2022
  • Latest Major Action March 28, 2022

Bill Version

Bill Summary

Protecting our Pharmaceutical Supply Chain from China Act of 2022 This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing ingredients manufactured in China, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives. The Food and Drug Administration shall maintain (1) a list of...

(Source: Library of Congress)

Bill Actions

Date Description
March 28, 2022
Referred to the Subcommittee on Health.
March 18, 2022
Referred to the Subcommittee on Health.
March 17, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
March 17, 2022

Introduced in the House by Mike Gallagher (R-Wis.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page